Hogan Lovells advised OncoVerity on the deal. OncoVerity, a pioneer in applying advanced bioinformatics to drug development, announced the closing of a Series A extension financing...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised March Biosciences on the deal. March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, closed a...
You must be a Standard 1 Year member to access this content.
Locke Lord is representing Kinder Morgan in the transaction. Hogan Lovells is advising NextEra Energy Partners. Kinder Morgan, Inc. (NYSE: KMI) announced that it has agreed...
You must be a Standard 1 Year member to access this content.
